MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-MP-10-0012382
Albris Pharma LLP
Albris Pharma LLP - chemicals in New Delhi, Delhi, India. Directors, charges & compliance details.
Contribution obligation
₹1 Lakh
As per LLP agreement
LLP age
6 yrs
Est. 2020
Designated partners
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
LLP status
Active
MCA master data
Registrar
Delhi
ROC office
Incorporated
14 Oct 2020
Date of incorporation
Entity type
LLP
As registered with MCA
About Albris Pharma LLP
Data last updated:
Albris Pharma LLP is a limited liability partnership (LLP) based in New Delhi, Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 14 October 2020 and has been in existence for over 6 years.
The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAU-2368.
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Sharuti and Lalit Mohan Shrivastava.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at B 1421/39 Sant Nagar Burari, New Delhi, Delhi, India – 110084.
Albris Pharma LLP is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-10-0012382).
Company details
LLPIN AAU-2368
Incorporation Date 14 October 2020
Total Obligation of Contribution ₹1 Lakh
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MP-10-0012382
Recognitions & Rankings of Albris Pharma
Contact details
Albris Pharma LLP's registered office is in New Delhi, Delhi.
- Registered AddressB 1421/39 Sant Nagar Burari, New Delhi, Delhi, India – 110084
- IndustryChemicals, Manufacturing, Chemicals And Chemical Products
Comprehensive company report
Albris Pharma LLP - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Albris Pharma LLP
FY 2025 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | |||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | |||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Albris Pharma LLP, buy the company report.
Designated partners of Albris Pharma LLP
Albris Pharma has 2 designated partners on record. No former designated partners are listed.
Current Designated Partners
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sharuti Also directs: Enviroquest Pharmaceuticals Private Limited | Designated Partner | 14 Oct 2020 | 6 Years 0 Months | Current |
| Lalit Mohan Shrivastava Also directs: Enviroquest Pharmaceuticals Private Limited | Designated Partner | 14 Oct 2020 | 6 Years 0 Months | Current |
Legal cases
No court or tribunal cases involving Albris Pharma LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Albris Pharma LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Albris Pharma LLP; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Albris Pharma LLP has 2 designated partner changes on record since 2020: 2 appointments. The latest: Lalit Mohan Shrivastava was appointed as Designated Partner on 14 Oct 2020.
AGM
Albris Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Albris Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Lalit Mohan Shrivastava was appointed as Designated Partner.
Appointed
Sharuti was appointed as Designated Partner.
Incorporation
14 Oct 2020
Albris Pharma Llp was registered on 14 Oct 2020 with Roc Delhi & aged 6 years 14 days as per MCA records.
Frequently asked questions
Albris Pharma is an active limited liability partnership based in New Delhi, Delhi, India. The LLP works in manufacturing, within the chemicals industry. It was incorporated on 14 October 2020 (6+ years old) and is registered under LLPIN AAU-2368.
Albris Pharma has 2 current designated partners:
- Sharuti - Designated Partner
- Lalit Mohan Shrivastava - Designated Partner
The latest financial statements of Albris Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2021 are in the company report.
The LLPIN (Limited Liability Partnership Identification Number) of Albris Pharma is AAU-2368. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Albris Pharma was incorporated on 14 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Lalit Mohan Shrivastava was appointed as Designated Partner on 14 Oct 2020. Sharuti was appointed as Designated Partner on 14 Oct 2020.
Yes, Albris Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-10-0012382).
The registered office of Albris Pharma is at B 142139 Sant Nagar Burari, New Delhi, Delhi, India – 110084.
Albris Pharma operates in the chemicals industry, in the manufacturing segment.
Albris Pharma can be reached at its registered office: B 142139 Sant Nagar Burari, New Delhi, Delhi, India – 110084.